Sector
PharmaceuticalsOpen
₹36.39Prev. Close
₹36.19Turnover(Lac.)
₹35.84Day's High
₹38.19Day's Low
₹35.7352 Week's High
₹77.752 Week's Low
₹34.11Book Value
₹6.32Face Value
₹10Mkt Cap (₹ Cr.)
286.23P/E
37.35EPS
1Divi. Yield
024 May 2024
12:00 AM
AGM
Announcement Date: 24 May, 2024
22 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 76.63 | 76.63 | 76.63 | 76.63 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -36.34 | -38.79 | -42.93 | -45.85 |
Net Worth | 40.29 | 37.84 | 33.7 | 30.78 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 0 | 0 | 0.92 | 1.51 |
yoy growth (%) | 0 | -100 | -38.83 | -78.37 |
Raw materials | 0 | 0 | -0.57 | -0.99 |
As % of sales | 0 | 0 | 62.47 | 65.65 |
Employee costs | -3.26 | -3.34 | -4.55 | -7.36 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -9.46 | 15.9 | 2.18 | -18.66 |
Depreciation | -0.37 | -0.38 | -0.41 | -2.44 |
Tax paid | 0.08 | -0.35 | -3.62 | -1.9 |
Working capital | 19.52 | 14.58 | -2.48 | -17.96 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | -100 | -38.83 | -78.37 |
Op profit growth | 385.77 | -62.33 | 1.08 | -4.7 |
EBIT growth | -154.43 | 406.44 | -120.14 | -126.88 |
Net profit growth | -160.36 | -1,181.15 | -93 | -145.01 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 196.19 | 173.57 | 170.28 | 196.75 | 163.64 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 196.19 | 173.57 | 170.28 | 196.75 | 163.64 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 12.02 | 10.37 | 12.49 | 48.44 | 39.69 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.3 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,613.75 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,512.75 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.2 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,225.7 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman
Kartikeya V Sarabhai
Whole-time Director
Chaula Shastri
Company Sec. & Compli. Officer
Damodar Sejpal
Independent Director
Mayur K Swedia
Independent Director
BRIJESH KHANDELWAL
Independent Director
Govindprasad Namdeo
Non Executive Director
Ajay Mayor
Non Executive Director
Bharatendu Jani
Managing Director
Mohal Kartikeya Sarabhai
Independent Director
Pushpa Robin
Independent Director
Satyen Dave
Shanti Sadan,
Mirzapur Road,
Gujarat - 380001
Tel: 91-79-25507671/25507073
Website: http://www.ase.life
Email: [email protected]
Neelam Apt 88,
Sampat Rao Colony, Po Race Course,
Vadodara 390007
Tel: 91-0265-2339397
Website: www.mcsdel.com
Email: [email protected]
Summary
Ambalal Sarabhai Enterprises Ltd., incorporated on June 5, 1978, houses a range of companies across multi-dimensional businesses. Each subsidiary is a distinct entity contributing its unique expertise...
Read More
Reports by Ambalal Sarabhai Enterprises Ltd
What is the Ambalal Sarabhai Enterprises Ltd share price today?
What is the Market Cap of Ambalal Sarabhai Enterprises Ltd?
What is the PE and PB ratio of Ambalal Sarabhai Enterprises Ltd?
What is the 52 Week High and Low of Ambalal Sarabhai Enterprises Ltd?
What is the CAGR of Ambalal Sarabhai Enterprises Ltd?
What is the shareholding pattern of Ambalal Sarabhai Enterprises Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.